Prostaglandin E2 enhances Th17 responses via modulation of IL-17 and IFN-gamma production by memory CD4+ T cells (Q46041262)

18 December 2017

title

Prostaglandin E2 enhances Th17 responses via modulation of IL-17 and IFN-gamma production by memory CD4+ T cells (English)

1 reference

18 December 2017

1 reference

2

1 reference

18 December 2017

Antonio Lanzavecchia

series ordinal

3

object named as

Antonio Lanzavecchia

1 reference

18 December 2017

4

Federica Sallusto

0 references

author name string

Giorgio Napolitani

series ordinal

1

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 May 2009

1 reference

18 December 2017

European Journal of Immunology

published in

1 reference

18 December 2017

volume

39

1 reference

18 December 2017

page(s)

1301-1312

1 reference

18 December 2017

issue

5

1 reference

18 December 2017

Transforming growth factor-beta induces development of the T(H)17 lineage

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Induction, function and regulation of IL-17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Induction and effector functions of T(H)17 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Development, cytokine profile and function of human interleukin 17-producing helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

IL-21 and TGF-beta are required for differentiation of human T(H)17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Phenotypic and functional features of human Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Increased expression of interleukin 17 in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Paradoxical roles of IFN-gamma in models of Th1-mediated autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Evolving concepts of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Regulation of IL-17 in human CCR6+ effector memory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Drug insight: cyclo-oxygenase-2 inhibitors--a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

IL-17 family cytokines and the expanding diversity of effector T cell lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

A novel transcription factor, T-bet, directs Th1 lineage commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Foxp3 inhibits RORgammat-mediated IL-17A mRNA transcription through direct interaction with RORgammat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Cytokines and T-cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Distribution and function of prostanoid receptors: studies from knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Chronic relapsing homologous collagen-induced arthritis in DBA/1 mice as a model for testing disease-modifying and remission-inducing therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Psoriatic arthritis therapy: NSAIDs and traditional DMARDs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Prostaglandins as modulators of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Distinct and Nonredundant In Vivo Functions of IFNAR on Myeloid Cells Limit Autoimmunity in the Central Nervous System

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

7 January 2021

IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

7 January 2021

Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

7 January 2021

Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

7 January 2021

Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

7 January 2021

High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

7 January 2021

Development of anti-TNF therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

7 January 2021

Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

7 January 2021

Prostanoid receptors: structures, properties, and functions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

7 January 2021

Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

7 January 2021

Type I interferons as anti-inflammatory mediators

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838969

7 January 2021

Identifiers

DOI

10.1002/EJI.200838969

1 reference

18 December 2017

PubMed ID

19384872

1 reference

18 December 2017